These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 4749859)

  • 41. The isoxazolyl penicillins: oxacillin, cloxacillin, and dicloxacillin.
    Marcy SM; Klein JO
    Med Clin North Am; 1970 Sep; 54(5):1127-43. PubMed ID: 4919148
    [No Abstract]   [Full Text] [Related]  

  • 42. Acquired and native resistance of Staphylococcus aureus to cephalexin and other beta-lactam antibiotics.
    Kayser FH; Benner EJ; Hoeprich PD
    Appl Microbiol; 1970 Jul; 20(1):1-5. PubMed ID: 5201887
    [TBL] [Abstract][Full Text] [Related]  

  • 43. EUCAST Technical Note on daptomycin.
    European Committee on Antimicrobial Susceptibility Testing (EUCAST) Steering Committee
    Clin Microbiol Infect; 2006 Jun; 12(6):599-601. PubMed ID: 16700717
    [No Abstract]   [Full Text] [Related]  

  • 44. In vitro antimicrobial activity of 6(D(-) -amino-p-hydroxyphenylacetamido) penicillanic acid, a new semisynthetic penicillin.
    Neu HC; Winshell EB
    Antimicrob Agents Chemother (Bethesda); 1970; 10():407-10. PubMed ID: 4398823
    [No Abstract]   [Full Text] [Related]  

  • 45. Enhancement of host defense mechanisms against gram-positive pyogenic coccal infections with levo-tetramisole (levamisole) in neonatal rats.
    Fisher GW; Oi VT; Kelley JL; Podgore JK; Bass JW; Wagner FS; Gordon BL
    Ann Allergy; 1974 Oct; 33(4):193-8. PubMed ID: 4413243
    [No Abstract]   [Full Text] [Related]  

  • 46. [Semisynthetic penicillins from the group of isoxazolyl derivatives of 6 AP acid].
    Tubylewicz H; Sadowski Z
    Wiad Lek; 1972 May; 25(9):789-96. PubMed ID: 4556533
    [No Abstract]   [Full Text] [Related]  

  • 47. Clinical, laboratory, and pharmacological studies of dicloxacillin.
    Hammerstrom CF; Cox F; McHenry MC; Quinn EL
    Antimicrob Agents Chemother (Bethesda); 1966; 6():69-74. PubMed ID: 5982342
    [No Abstract]   [Full Text] [Related]  

  • 48. The Devil is in the Details: Impact of Penicillin Susceptibility Reporting on the Treatment of Streptococcal Infective Endocarditis.
    Chow SK; Jain R; Black D; Pottinger PS; Fang FC; Butler-Wu SM
    Clin Infect Dis; 2016 Jan; 62(2):264-5. PubMed ID: 26400995
    [No Abstract]   [Full Text] [Related]  

  • 49. Comparison of cephalexin, oxacillin, cloxacillin, dicloxacillin and nafcillin in streptococcal infections in monkeys.
    Saslaw S; Carlisle HN
    Am J Med Sci; 1970 Jun; 259(6):383-93. PubMed ID: 4987196
    [No Abstract]   [Full Text] [Related]  

  • 50. In vitro and in vivo evaluation of enduracidin, a new peptide antibiotic substance.
    Goto S; Kuwahara S; Okubo N; Zenyoji H
    J Antibiot (Tokyo); 1968 Feb; 21(2):119-25. PubMed ID: 4299887
    [No Abstract]   [Full Text] [Related]  

  • 51. Terpene compounds as drugs. 8. Bacteriological and pharmacological properties of terpenyl penicillins.
    Pala G; Casadio S; Coppi G; Crescenzi E; Mantegani A
    Arzneimittelforschung; 1970 Jan; 20(1):62-8. PubMed ID: 4986283
    [No Abstract]   [Full Text] [Related]  

  • 52. Dicloxacillin versus triacetyloleandomycin in upper respiratory infections caused by beta-hemolytic streptococci.
    Mesches DN; Pugliese W; Wiersum J; Taylor RB; Henriquez CL
    N Y State J Med; 1968 Aug; 68(16):2164-7. PubMed ID: 5302159
    [No Abstract]   [Full Text] [Related]  

  • 53. [Studies on antibacterial effect of penicillin V, tetracycline and penimepicycline].
    Rogala D; Holowiecka D; Herman Z; Skrzypczak S
    Pol Tyg Lek; 1969 Mar; 24(12):442-4. PubMed ID: 5768695
    [No Abstract]   [Full Text] [Related]  

  • 54. In vitro antimicrobial activity of a new semisyntheti penicillin, BL-P 1654 (6-(R- -(guanylureido) phenylacetamido)-penicillanic acid).
    Van Scoy RE; Warren E; Washington JA
    Antimicrob Agents Chemother (Bethesda); 1970; 10():12-6. PubMed ID: 4939731
    [No Abstract]   [Full Text] [Related]  

  • 55. Duration of therapeutic activity of aminoalicyclic penicillins against bacterial infections in mice.
    Hopper MW; Yurchenco JA; Warren GH
    Antimicrob Agents Chemother (Bethesda); 1967; 7():597-601. PubMed ID: 5596196
    [No Abstract]   [Full Text] [Related]  

  • 56. [Cephalexin: microbiological activity in vitro and in vivo].
    Muggleton PW; Renzini G; Ravagnan G; Orsolini P
    Antibiotica; 1969 Jun; 7(2):93-128. PubMed ID: 5399239
    [No Abstract]   [Full Text] [Related]  

  • 57. [Clinical application of methyldichlorophenylisoxazolyl penicillin (Dicloxacillin, Staphcillin A) for urinary tract infections, especially for non-gonorrheal urethritis].
    Ishigami J; Hara S; Yamura J
    J Antibiot B; 1966 Oct; 19(5):354-7. PubMed ID: 5298324
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical use of sodium nafcillin in pediatric practice.
    Nathan LA
    Curr Ther Res Clin Exp; 1965 Nov; 7(11):701-6. PubMed ID: 4378651
    [No Abstract]   [Full Text] [Related]  

  • 59. The correlation of in vitro tests with the outcome of antimicrobial therapy for otitis media.
    McCabe WR
    Pediatr Ann; 1984 May; 13(5):365-8. PubMed ID: 6564507
    [No Abstract]   [Full Text] [Related]  

  • 60. [Studies of the sensitivity of Staphylococcus aureus strains to antibiotics].
    Tubylewicz H; Sadowski Z
    Pol Tyg Lek; 1970 Aug; 25(33):1242-4. PubMed ID: 5202388
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.